发现和特征Zelnecirnon (RPT193),一个强大的和选择性的CCR4对抗剂对过敏性疾病
Mikhail Zibinsky1, Delia Bradford1, Dirk G Brockstedt1
1RAPT Therapeutics, 561 Eccles Avenue, South San Francisco, California 94080, United States.
Journal of medicinal chemistry
|January 23, 2026
概括
泽尔内锡龙 (RPT193) 是一种新型的小分子CCR4抗剂,有效阻止过敏免疫细胞迁移. 这种药物显示出作为一种口服治疗阿托皮性皮肤炎等过敏疾病的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在过敏性疾病中,CCR4通路至关重要,它调解了T辅助型2 (Th2) 细胞向炎症组织的迁移.
- CCR4对抗是一种潜在的治疗策略,可以缓解过敏性疾病的进展.
研究的目的:
- 发现和描述Zelnecirnon (RPT193),一种强效和选择性的小分子CCR4抗剂.
- 评估Zelnecirnon在亚托皮性皮肤炎体内模型中的疗效.
主要方法:
- 发现Zelnecirnon (RPT193) 作为一个小分子CCR4抗剂.
- 在体外评估CCR4诱导的化学毒素抑制和受体表达.
- 在亚托皮性皮肤炎模型中的体内评估.
主要成果:
- 泽尔尼西龙有效地抑制了CCR4诱导的化学反应,并减少了CCR4的表面表达.
- 该化合物具有有利的类似药物和DMPK特性.
- 在体内,Zelnecirnon在阿托皮性皮肤炎模型中显示出与已批准的生物药物相当的疗效.
结论:
- 泽尔内锡农是一种具有治疗潜力的强效和选择性CCR4抗剂.
- 展示了过敏性疾病中CCR4对抗性的概念证明.
- 代表了一种潜在的口服替代现有的生物疗法对过敏条件.
更多相关视频
07:01Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
Published on: September 16, 2022
2.2K
07:24Paramagnetic Relaxation Enhancement for Detecting and Characterizing Self-Associations of Intrinsically Disordered Proteins
Published on: September 23, 2021
2.2K
相关概念视频
Allergic Reactions
32.2K
Overview
32.2K
Allergic Drug Reactions
1.4K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.4K
Cholinergic Antagonists: Pharmacokinetics
922
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
922
Drug Discovery: Overview
11.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.3K
Intrinsically Disordered Proteins
19.3K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.3K
Cholinergic Antagonists: Therapeutic Uses
1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
